Journal article

Inhibition of the cellular function of perforin by 1-amino-2,4- dicyanopyrido[1,2-a]benzimidazoles

DM Lyons, KM Huttunen, KA Browne, A Ciccone, JA Trapani, WA Denny, JA Spicer

Bioorganic and Medicinal Chemistry | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2011

Abstract

A high throughput screen showed the ability of a 1-amino-2,4- dicyanopyrido[1,2-a]benzimidazole analogue to directly inhibit the lytic activity of the pore-forming protein perforin. A series of analogues were prepared to study structure-activity relationships (SAR) for the this activity, either directly added to cells or released in situ by KHYG-1 NK cells, at non-toxic concentrations. These studies showed that the pyridobenzimidazole moiety was required for effective activity, with strongly basic centres disfavoured. This class of compounds was relatively unaffected by the addition of serum, which was not the case for a previous class of direct inhibitors. © 2011 Elsevier Ltd. All rights re..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Academy of Finland


Funding Acknowledgements

The authors thank the Wellcome Trust for partial support. K.M.H. thanks the Academy of Finland (Grant no. 135439), the Finnish Cultural Foundation, and Jenny and Antti Wihuri Foundation for financial support.